ProCE Banner Activity

Omicron Variant and Monoclonal Antibody Treatments for COVID-19

Multimedia
Hear expert insights on how the omicron variant is affecting monoclonal antibody treatments for COVID-19.

Released: February 21, 2022

Expiration: February 20, 2023

No longer available for credit.

Share

Faculty

Arthur Kim

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Arthur Kim, MD

Associate Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD, has disclosed that he is on the drug and safety monitoring board of Kintor.